(Q39506446)

English

Two patients with all-trans retinoic acid-resistant acute promyelocytic leukemia treated successfully with gemtuzumab ozogamicin as a single agent

scientific article published on December 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 September 2017

Two patients with all-trans retinoic acid-resistant acute promyelocytic leukemia treated successfully with gemtuzumab ozogamicin as a single agent (English)

1 reference

Europe PubMed Central

12 September 2017

acute promyelocytic leukemia

1 reference

based on heuristic

inferred from title

author name string

Akihiro Takeshita

1

1 reference

Europe PubMed Central

12 September 2017

Kaori Shinjo

2

1 reference

Europe PubMed Central

12 September 2017

Kensuke Naito

3

1 reference

Europe PubMed Central

12 September 2017

Hirotaka Matsui

4

1 reference

Europe PubMed Central

12 September 2017

Naohi Sahara

5

1 reference

Europe PubMed Central

12 September 2017

Kazuyuki Shigeno

6

1 reference

Europe PubMed Central

12 September 2017

Taeko Suzumura

7

1 reference

Europe PubMed Central

12 September 2017

Toshinobu Horii

8

1 reference

Europe PubMed Central

12 September 2017

Naohito Shirai

9

1 reference

Europe PubMed Central

12 September 2017

Masato Maekawa

10

1 reference

Europe PubMed Central

12 September 2017

Yoshihiro Yada

11

1 reference

Europe PubMed Central

12 September 2017

Hirofumi Teshima

12

1 reference

Europe PubMed Central

12 September 2017

Jin Takeuchi

13

1 reference

Europe PubMed Central

12 September 2017

Kazunori Ohnishi

14

1 reference

Europe PubMed Central

12 September 2017

Ryuzo Ohno

15

1 reference

Europe PubMed Central

12 September 2017

publication date

1 December 2005

1 reference

Europe PubMed Central

12 September 2017

International Journal of Hematology

1 reference

Europe PubMed Central

12 September 2017

82

1 reference

Europe PubMed Central

12 September 2017

445-448

1 reference

Europe PubMed Central

12 September 2017

5

1 reference

Europe PubMed Central

12 September 2017

https://scigraph.springernature.com/pub.10.1532/ijh97.05069

0 references

Analysis of prognostic factors in newly diagnosed patients with acute promyelocytic leukemia: the APL92 study of the Japan Adult Leukemia Study Group (JALSG).

1 reference

https://pubmed.ncbi.nlm.nih.gov/16533750

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of gemtuzumab ozogamicin on ATRA- and arsenic-resistant acute promyelocytic leukemia (APL) cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/16533750

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Significantly lower P-glycoprotein expression in acute promyelocytic leukemia than in other types of acute myeloid leukemia: immunological, molecular and functional analyses.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16533750

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of acute promyelocytic leukemia: strategy toward further increase of cure rate

1 reference

https://pubmed.ncbi.nlm.nih.gov/16533750

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Calicheamicin-conjugated humanized anti-CD33 monoclonal antibody (gemtuzumab zogamicin, CMA-676) shows cytocidal effect on CD33-positive leukemia cell lines, but is inactive on P-glycoprotein-expressing sublines.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16533750

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized study of individualized induction therapy with or without VCR, and of maintenance of 4 or 12 courses in adult AML: JALSG-AML87. Japan Adult Leukemia Study Group (JALSG)

1 reference

https://pubmed.ncbi.nlm.nih.gov/16533750

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Experience with gemtuzumab ozogamycin ("mylotarg") and all-trans retinoic acid in untreated acute promyelocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/16533750

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular remission induction with retinoic acid and anti-CD33 monoclonal antibody HuM195 in acute promyelocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/16533750

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

P-glycoprotein (P-gp) and multidrug resistance-associated protein 1 (MRP1) are induced by arsenic trioxide (As(2)O(3)), but are not the main mechanism of As(2)O(3)-resistance in acute promyelocytic leukemia cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/16533750

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of P-glycoprotein in all-trans retinoic acid (ATRA) resistance in acute promyelocytic leukaemia cells: analysis of intracellular concentration of ATRA.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16533750

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gemtuzumab ozogamicin (Mylotarg) as a single agent for molecularly relapsed acute promyelocytic leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16533750

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced effect of gemtuzumab ozogamicin (CMA-676) on P-glycoprotein and/or CD34-positive leukemia cells and its restoration by multidrug resistance modifiers

1 reference

https://pubmed.ncbi.nlm.nih.gov/16533750

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of multidrug resistance P-glycoprotein in myeloid progenitor cells of different phenotype: comparison between normal bone marrow cells and leukaemia cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/16533750

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful treatment of relapse of acute promyelocytic leukemia with a new synthetic retinoid, Am80

1 reference

https://pubmed.ncbi.nlm.nih.gov/16533750

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New advances in the treatment of acute promyelocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/16533750

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1532/IJH97.05069

1 reference

Europe PubMed Central

12 September 2017

Dimensions Publication ID

0 references

release_66jsx3hla5dungtduukg7rymoy

0 references

1 reference

Europe PubMed Central

12 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39506446&oldid=1833016414"